Liyun Cao

1.4k total citations
25 papers, 945 citations indexed

About

Liyun Cao is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Liyun Cao has authored 25 papers receiving a total of 945 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 7 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Liyun Cao's work include Blood properties and coagulation (5 papers), COVID-19 Clinical Research Studies (3 papers) and Erythrocyte Function and Pathophysiology (2 papers). Liyun Cao is often cited by papers focused on Blood properties and coagulation (5 papers), COVID-19 Clinical Research Studies (3 papers) and Erythrocyte Function and Pathophysiology (2 papers). Liyun Cao collaborates with scholars based in United States, China and Russia. Liyun Cao's co-authors include Daniela Matei, Minati Satpathy, Harikrishna Nakshatri, Salvatore Condello, Theresa A. Guise, Khalid S. Mohammad, Mingjie Shao, Jeanne M. Schilder, Robert M. Bigsby and Robert E. Emerson and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Oncogene.

In The Last Decade

Liyun Cao

21 papers receiving 937 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liyun Cao United States 14 350 293 279 133 110 25 945
Toshiyuki Sumi Japan 16 297 0.8× 257 0.9× 226 0.8× 109 0.8× 75 0.7× 138 803
Mitsugu Hironaka Japan 17 306 0.9× 300 1.0× 213 0.8× 90 0.7× 96 0.9× 49 1.0k
Susan Heavey United Kingdom 18 446 1.3× 129 0.4× 215 0.8× 196 1.5× 71 0.6× 49 905
Carmen Domı́nguez-Jiménez Spain 15 347 1.0× 202 0.7× 172 0.6× 163 1.2× 67 0.6× 20 1.4k
Tomoya Tsukada Japan 21 337 1.0× 409 1.4× 401 1.4× 144 1.1× 29 0.3× 66 1.1k
Joanna Trojanek Poland 17 329 0.9× 301 1.0× 200 0.7× 123 0.9× 72 0.7× 29 900
CS Potten United Kingdom 14 455 1.3× 271 0.9× 656 2.4× 195 1.5× 56 0.5× 15 1.3k
Masaki Mizumoto Japan 15 517 1.5× 193 0.7× 510 1.8× 320 2.4× 215 2.0× 24 1.5k
Hiroaki Shimoyamada Japan 20 426 1.2× 179 0.6× 218 0.8× 211 1.6× 71 0.6× 46 1.1k
Susanne A. Gatz United Kingdom 16 416 1.2× 187 0.6× 267 1.0× 88 0.7× 41 0.4× 35 887

Countries citing papers authored by Liyun Cao

Since Specialization
Citations

This map shows the geographic impact of Liyun Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liyun Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liyun Cao more than expected).

Fields of papers citing papers by Liyun Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liyun Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liyun Cao. The network helps show where Liyun Cao may publish in the future.

Co-authorship network of co-authors of Liyun Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Liyun Cao. A scholar is included among the top collaborators of Liyun Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liyun Cao. Liyun Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Liang, Liyun Cao, & X. Long Zheng. (2022). ADAMTS13 protease or lack of von Willebrand factor protects irradiation and melanoma‐induced thrombotic microangiopathy in zebrafish. Journal of Thrombosis and Haemostasis. 20(10). 2270–2283.
2.
Chang, Jeffrey T., David T. Redden, José Lima, Vishnu Reddy, & Liyun Cao. (2022). A retrospective study of the eGFR differences between the 2021 CKD-EPI Equation and the MDRD equation in Black and White Patients. American Journal of Clinical Pathology. 158(Supplement_1). S27–S27.
3.
Noubouossie, Denis F., et al.. (2021). Elevated Plasma Fibrinogen Is Associated With Excessive Inflammation and Disease Severity in COVID-19 Patients. Frontiers in Cellular and Infection Microbiology. 11. 734005–734005. 64 indexed citations
4.
Kelmenson, Daniel A., et al.. (2021). Acute Respiratory Distress Syndrome in a Patient With Acute Promyelocytic Leukemia: Overlapping Between Differentiation Syndrome and COVID-19. Journal of Hematology. 10(5). 217–220. 1 indexed citations
5.
Fei, Fei, John A. Smith, & Liyun Cao. (2020). Clinical laboratory characteristics in patients with suspected COVID‐19: One single‐institution experience. Journal of Medical Virology. 93(3). 1665–1671. 16 indexed citations
6.
Cao, Liyun, et al.. (2018). Combination of Prostate Cancer Antigen 3 and Prostate-Specific Antigen Improves Diagnostic Accuracy in Men at Risk of Prostate Cancer. Archives of Pathology & Laboratory Medicine. 142(9). 1106–1112. 13 indexed citations
7.
Cao, Liyun, et al.. (2017). Discordant Analytical Results Caused by Biotin Interference on Diagnostic Immunoassays in a Pediatric Hospital.. PubMed. 47(5). 638–640. 11 indexed citations
8.
Cao, Liyun, Wuqiang Zhu, Elizabeth A. Wagar, & Qing H. Meng. (2016). Biomarkers for monitoring chemotherapy-induced cardiotoxicity. Critical Reviews in Clinical Laboratory Sciences. 54(2). 87–101. 25 indexed citations
9.
Cao, Liyun, et al.. (2016). Causes and impact of specimen rejection in a clinical chemistry laboratory. Clinica Chimica Acta. 458. 154–158. 20 indexed citations
10.
Cao, Liyun, Elizabeth A. Wagar, & Qing H. Meng. (2015). A young boy with recurrent headache, lethargy, and hyponatremia. Clinica Chimica Acta. 454. 46–48.
11.
Condello, Salvatore, Cynthia A. Morgan, Sarbajeet Nagdas, et al.. (2014). β-Catenin-regulated ALDH1A1 is a target in ovarian cancer spheroids. Oncogene. 34(18). 2297–2308. 151 indexed citations
12.
Condello, Salvatore, Liyun Cao, & Daniela Matei. (2013). Abstract C49: Tissue tranglutaminase regulates β-catenin signaling in ovarian cancer cells. Cancer Research. 73(3_Supplement). C49–C49. 1 indexed citations
13.
Thomas, Mini, Andrea Caperell–Grant, Bhadrani Chelladurai, et al.. (2012). Abstract 3439: Tissue tranglutaminase (TG2) targeting by multifunctional field responsive gold nanoparticles. Cancer Research. 72(8_Supplement). 3439–3439. 12 indexed citations
14.
Dou, Yu, Haibo Liu, Pengcheng Xu, Liyun Cao, & Li Zuo. (2011). Comparison of bioimpedance methods for estimating total body water and intracellular water changes during hemodialysis. Nephrology Dialysis Transplantation. 26(10). 3319–3324. 27 indexed citations
15.
Dou, Yanna, Li Liu, Xinju Zhao, et al.. (2011). Development and Validation of a New Dry Weight Estimation Method Using Single Frequency Bioimpedance in Hemodialysis Patients. Blood Purification. 32(4). 278–285. 8 indexed citations
16.
Cao, Liyun, Mingjie Shao, Jeanne M. Schilder, et al.. (2011). Tissue transglutaminase links TGF-β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer. Oncogene. 31(20). 2521–2534. 185 indexed citations
17.
Shao, Minghai, Liyun Cao, Changyu Shen, et al.. (2009). Epithelial-to-Mesenchymal Transition and Ovarian Tumor Progression Induced by Tissue Transglutaminase. Cancer Research. 69(24). 9192–9201. 118 indexed citations
18.
Satpathy, Minati, Liyun Cao, Roxana Pincheira, et al.. (2007). Enhanced Peritoneal Ovarian Tumor Dissemination by Tissue Transglutaminase. Cancer Research. 67(15). 7194–7202. 102 indexed citations
19.
Matei, Daniela, Stephanie L. Kelich, Liyun Cao, et al.. (2007). PDGF BB induces VEGF secretion in ovarian cancer. Cancer Biology & Therapy. 6(12). 1951–1959. 61 indexed citations
20.
Matei, Daniela, et al.. (2006). The Platelet-derived Growth Factor Receptor α Is Destabilized by Geldanamycins in Cancer Cells. Journal of Biological Chemistry. 282(1). 445–453. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026